Massachusetts Drug Test Bill: H.2179 Scope, Exemptions, and Status

The Massachusetts drug test bill, formally House Bill 2179, would bar employers from firing, refusing to hire, demoting, or otherwise punishing a worker based on a positive marijuana test alone. To act on the result, the employer would need separate evidence that the person was actually impaired by cannabis at work or during work hours. As of early 2026, the bill has passed its first reading in the House and is awaiting a second reading, so it is not yet law.¹

What H.2179 Would Actually Do

Despite the broad “drug test bill” label it sometimes gets, H.2179 is narrow. It covers cannabis and nothing else. The protection runs to qualifying medical marijuana patients, and the trigger for losing that protection is reasonable suspicion of actual on-the-job impairment, not a laboratory result showing THC metabolites in a urine sample.¹

That distinction is the whole point of the bill. THC metabolites can linger in the body for days or weeks after any impairing effect has worn off. A worker who legally used cannabis on a Friday night can still fail a Monday morning test while being completely unimpaired at work. Under current Massachusetts law, that failed test can cost the person their job. Under H.2179, it could not, unless the employer could also point to signs of impairment during work hours.

The bill is equally clear about what it does not do. It would not require any employer to permit cannabis use, possession, or sale in the workplace. It would not touch employer policies on any other substance. And it would not override federal employment contracts or federal funding conditions.¹ Alcohol testing, opioid testing, cocaine testing, and the rest of a standard drug panel would continue to work exactly as they do today.

Who Would Be Exempt

Two large categories of workers would fall outside the bill’s protection.

The first is safety-sensitive positions. If your job involves duties where impairment could cause immediate, permanent physical injury or death to yourself or others, the cannabis protections would not apply.¹ The file points to heavy equipment operators, commercial drivers, and healthcare workers handling controlled substances as roles likely to qualify. For these jobs, employers could continue to treat a positive marijuana test as grounds for action.

The second is any employer whose compliance would force a violation of federal law, regulation, contract, or funding agreement.¹ This carve-out is significant. Marijuana remains a Schedule I substance under federal law as of March 2026, even with federal rescheduling to Schedule III under discussion. Federal agencies have confirmed that workplace drug testing panels will continue to include marijuana metabolites regardless of any rescheduling. Employers holding federal contracts, Department of Transportation-regulated employers, and others operating under federal mandates would keep testing for marijuana and acting on positive results exactly as federal rules require.

Companies with federal contracts above the simplified acquisition threshold of $350,000 fall under the Drug-Free Workplace Act, which requires a policy prohibiting controlled substances in the workplace, an awareness program, and sanctions for drug-related offenses.² DOT’s Part 40 regulations go further, requiring marijuana testing for safety-sensitive transportation workers and stating that the consequences of a positive or refused test “cannot be overturned or set aside by an arbitration, grievance, State court or other non-Federal forum.”³ H.2179 would not change any of that.

Where the Bill Stands

H.2179 has passed its first reading in the Massachusetts House and is awaiting a second reading.¹ It has not been enacted, and nothing in it binds Massachusetts employers today. Workers who are considering their options and employers reviewing their policies both need to understand that the current legal framework, not the bill, controls every testing decision being made right now.

What Massachusetts Law Allows Today

Massachusetts has no comprehensive drug testing statute. The rules come primarily from court decisions interpreting the state constitution’s privacy protections, together with a statutory right of privacy under Massachusetts General Laws Chapter 214, Section 1B.⁴ That makes the baseline rules more employee-friendly than in many other states, and it is the reason H.2179 is building on an already restrictive foundation rather than starting from scratch.

The leading case is Webster v. Motorola, Inc., decided by the Massachusetts Supreme Judicial Court in 1994. The court held that an employer’s general desire for a drug-free workplace is not, by itself, enough to justify random drug testing when weighed against an employee’s privacy interests. Instead, courts apply a case-by-case balancing test: the employer’s specific business interest must outweigh the employee’s reasonable expectation of privacy. Webster also established confidentiality expectations around test results: results should be verified by an independent Medical Review Officer and flow only to personnel who need the information for employment decisions, not routinely to supervisors.⁵

Where the balance tips toward the employer is in genuinely safety-sensitive roles. In O’Connor v. Police Commissioner of Boston (1990), the court upheld suspicionless urinalysis testing of police cadets, pointing to the public interest in keeping drug-impaired people away from firearms, emergency situations, and law enforcement duties. The cadets had also agreed in writing to testing as a condition of employment.⁶

Pulled together, these are the testing situations Massachusetts employers can generally defend today, provided they follow proper procedures:

Pre-employment testing as a condition of a job offer, when the requirement is disclosed in advance and applied consistently.
Reasonable-suspicion testing when a supervisor documents specific, observable indicators of impairment. Vague hunches do not hold up.
Post-accident testing, particularly when the employee’s conduct could have contributed to the incident. OSHA’s injury recording rule permits this when the test serves a legitimate safety purpose rather than punishing an employee for reporting an injury.⁷
Random testing for safety-sensitive positions where the Webster balancing test favors the employer. Random testing of office workers or similar roles without clear safety stakes is legally risky in Massachusetts.

On marijuana specifically, current Massachusetts law does not require evidence of on-the-job impairment before an employer can act on a positive test. The Americans with Disabilities Act does not help either, because cannabis remains federally illegal and current marijuana users are not considered persons with a disability under the ADA.⁸ That gap is exactly what H.2179 is designed to close.

Prescription Medications Already Have Protection

Drug tests can flag legally prescribed medications, including opioids, amphetamines used in ADHD treatment, and benzodiazepines. The ADA already offers protection here. An employer who takes action based on a positive test caused by a lawfully prescribed drug can face disability discrimination liability, and the employer is expected to determine whether the result stems from legal medication before acting.⁸ Prescription information disclosed through the testing process must be stored as confidential medical records, separate from regular personnel files. H.2179 does not change this; it addresses the one category the ADA leaves out.

What Would Change in Practice If H.2179 Passes

For employees who use cannabis legally outside of work and whose jobs are not safety-sensitive or federally regulated, the shift is substantial. A positive marijuana test on a routine screen would no longer, by itself, be grounds for firing, demotion, or a withdrawn job offer. The employer would need to show reasonable suspicion of actual impairment at work.¹

For employers, the change in daily practice comes down to one line in a policy. Where a current policy might treat any positive drug screen as grounds for action, a compliant post-H.2179 policy would separate marijuana from other substances and require documented evidence of on-the-job impairment before a marijuana result can trigger discipline. Supervisor documentation of observable impairment indicators becomes the pivot point for any marijuana-related action, in the same way it already is for a reasonable-suspicion test under current Massachusetts law.

Employers in the two exempt categories, safety-sensitive roles and federally regulated or federally contracted workplaces, would see no required change to their marijuana testing programs. Their obligations under DOT Part 40, the Drug-Free Workplace Act, and similar federal frameworks continue to apply, and H.2179 explicitly steps aside where federal rules would conflict.¹

Until the bill moves past a second reading and through the rest of the legislative process, none of this is binding. The Webster framework, the ADA, and the federal rules described above are the law Massachusetts workers and employers are operating under today, and anyone making a decision about a drug test or a positive result should be looking at that framework rather than at the proposed bill.

1
General Court of Massachusetts. Bill H.2179 – An Act Prohibiting Employment Discrimination Based on the Legal Use of Cannabis
2
Office of the Law Revision Counsel. Drug-Free Workplace Requirements for Federal Contractors
3
eCFR. Part 40 Procedures for Transportation Workplace Drug and Alcohol Testing Programs
4
Mass.gov. Massachusetts Law About Employee Privacy
5
Justia Case Law. Webster v. Motorola, Inc.
6
Justia Law. O’Connor v. Police Commissioner of Boston
7
Occupational Safety and Health Administration. Clarification of OSHA’s Position on Workplace Safety Incentive Programs and Post-Incident Drug Testing Under 29 CFR 1904.35(b)(1)(iv)
8
U.S. Commission on Civil Rights. Substance Abuse Under the ADA